All Practice Exams

Free Practice Questions for Iraqi Board Cardiology

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Exam Review

Key Facts: Iraqi Board Cardiology Exam

IBMS / MOHESR

Governing Body & Ministry

Iraqi Board for Medical Specializations

3 Years (+2 Core)

Fellowship Program Duration

IBMS Cardiology Curriculum

Not published

Published Pass Mark

Scientific Council of Cardiology curriculum

100 MCQs

Practice Bank Study Items

OpenExamPrep

The Iraqi Board of Cardiology (IBMS/MOHESR) qualification involves a 3-year subspecialty fellowship (total 5 years postgraduate training) assessed via the Part 1 Primary Written Exam (cardiovascular physiology, pharmacology, and imaging fundamentals) and the Part 2 Final Examination (written MCQ papers, clinical OSCE, echocardiography/angiography review, oral viva, and dissertation defense). This independent 100-question MCQ practice bank supports preparation for the theoretical written papers of Part 1 and Part 2; it is not a clinical simulator or a substitute for accredited clinical fellowship training.

Sample Iraqi Board Cardiology Practice Questions

Try these sample questions to review concepts for the Iraqi Board Cardiology exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1On a standard left ventricular pressure-volume loop, which mechanical event corresponds precisely to the transition from the isovolumetric contraction phase to the ventricular ejection phase?
A.Closure of the mitral valve
B.Opening of the aortic valve
C.Closure of the aortic valve
D.Opening of the mitral valve
Explanation: On a left ventricular pressure-volume loop, isovolumetric contraction occurs between mitral valve closure (bottom right corner, end-diastolic volume) and aortic valve opening (top right transition). Once left ventricular pressure exceeds aortic diastolic pressure, the aortic valve opens and ejection commences. Mitral valve closure marks the start of isovolumetric contraction, aortic valve closure marks the start of isovolumetric relaxation, and mitral valve opening marks the start of diastolic filling.
2Which phase of the ventricular cardiomyocyte action potential is predominantly driven by the rapid inactivation of L-type calcium channels combined with outward delayed rectifier potassium currents (IKr and IKs)?
A.Phase 0
B.Phase 1
C.Phase 2
D.Phase 3
Explanation: Phase 3 represents rapid repolarization of the ventricular myocardial action potential. It is mediated by the closure/inactivation of voltage-gated L-type calcium channels and the unopposed efflux of potassium through rapid (IKr) and slow (IKs) delayed rectifier potassium channels. Phase 0 is rapid depolarization via inward sodium current (INa), Phase 1 is early transient repolarization (Ito), and Phase 2 is the plateau phase where inward calcium influx balances potassium efflux.
3According to the Law of Laplace (Wall Stress = [Pressure x Radius] / [2 x Wall Thickness]), which compensatory myocardial remodeling mechanism directly minimizes left ventricular systolic wall stress in response to chronic pressure overload from severe aortic stenosis?
A.Eccentric hypertrophy with chamber dilation
B.Concentric hypertrophy with increased wall thickness
C.Myocyte apoptosis with wall thinning
D.Increased left ventricular end-diastolic radius
Explanation: Laplace's Law states that myocardial wall stress (afterload) is directly proportional to intracavity pressure and radius, and inversely proportional to twice the wall thickness (sigma = P x r / 2h). In chronic pressure overload such as aortic stenosis, sarcomeres are added in parallel, causing concentric hypertrophy (increased wall thickness 'h'). This increase in denominator normalizes systolic wall stress despite markedly elevated intraventricular systolic pressures.
4An acute, isolated increase in left ventricular afterload (e.g., sudden systemic vasoconstriction) will produce which immediate change on the ventricular pressure-volume loop before autonomic reflex compensation?
A.Increased stroke volume and decreased end-systolic volume
B.Decreased stroke volume and increased end-systolic volume
C.Decreased end-systolic pressure and increased stroke volume
D.Decreased end-diastolic volume with unchanged end-systolic volume
Explanation: When afterload increases acutely without an initial change in contractility, the ventricle faces higher resistance to ejection. Ejection ceases at a higher end-systolic pressure along the end-systolic pressure-volume relationship (ESPVR) line, resulting in an increased end-systolic volume (ESV) and a smaller stroke volume (SV = EDV - ESV). In subsequent beats, venous return adds to the residual ESV, elevating end-diastolic volume and engaging the Frank-Starling mechanism to restore stroke volume.
5Which physiological factor is the primary determinant of coronary blood flow to the left ventricular subendocardium under normal resting conditions?
A.Systolic aortic pressure
B.Diastolic perfusion time and coronary perfusion pressure
C.Heart rate acceleration during exercise
D.Right atrial pressure elevation
Explanation: Because high intramyocardial tissue pressure during left ventricular systole compresses subendocardial microvessels, over 80% of left coronary blood flow occurs during diastole. Coronary perfusion pressure is defined as aortic diastolic pressure minus left ventricular end-diastolic pressure (or coronary sinus/right atrial pressure). Therefore, diastolic perfusion time (which decreases disproportionately with tachycardia) and diastolic aortic pressure are the primary determinants of left ventricular myocardial perfusion.
6A right heart catheterization reveals a mean pulmonary artery pressure (mPAP) of 38 mmHg, a pulmonary capillary wedge pressure (PCWP) of 14 mmHg, and a thermodilution cardiac output of 4.0 L/min. What is the calculated pulmonary vascular resistance (PVR) in Wood units?
A.2.0 Wood units
B.4.0 Wood units
C.6.0 Wood units
D.9.5 Wood units
Explanation: Pulmonary vascular resistance (PVR) in Wood units is calculated as: PVR = (mean PAP - PCWP) / Cardiac Output. Substituting the values: (38 - 14) / 4.0 = 24 / 4.0 = 6.0 Wood units. A PVR greater than 2.0 Wood units (or > 3.0 Wood units by traditional criteria) signifies pre-capillary pulmonary hypertension.
7Using the direct Fick principle, a patient has a resting oxygen consumption (VO2) of 240 mL O2/min, an arterial oxygen content (CaO2) of 19 mL O2/dL, and a mixed venous oxygen content (CvO2) of 14 mL O2/dL. What is the patient's cardiac output?
A.3.2 L/min
B.4.8 L/min
C.5.5 L/min
D.6.4 L/min
Explanation: The direct Fick equation states: Cardiac Output (L/min) = VO2 (mL/min) / [ (CaO2 - CvO2) in mL/L ]. The arteriovenous oxygen difference is 19 - 14 = 5 mL O2/dL blood, which equals 50 mL O2/L blood. Cardiac output = 240 mL/min / 50 mL/L = 4.8 L/min.
8A 68-year-old man in the CCU with decompensated heart failure and elevated systemic vascular resistance is started on milrinone. What is the cellular mechanism of action of milrinone?
A.Selective stimulation of myocardial beta-1 adrenergic receptors
B.Inhibition of phosphodiesterase-3, increasing intracellular cyclic AMP
C.Direct stimulation of soluble guanylyl cyclase, increasing cGMP
D.Sensitization of cardiac troponin C to intracellular calcium ions
Explanation: Milrinone is a selective phosphodiesterase-3 (PDE-3) inhibitor. By preventing the breakdown of cyclic adenosine monophosphate (cAMP) in cardiomyocytes, it increases protein kinase A activation and intracellular calcium influx, conferring positive inotropy. In vascular smooth muscle, elevated cAMP promotes calcium extrusion and uptake into the sarcoplasmic reticulum, causing potent systemic and pulmonary vasodilation ('inodilator' effect).
9A 54-year-old man in cardiogenic shock has refractory hypotension despite norepinephrine. Vasopressin is added at 0.03 units/min. Through which receptor subtype does vasopressin exert its primary vasoconstrictor action?
A.V1a receptors coupled to Gq proteins on vascular smooth muscle
B.V2 receptors coupled to Gs proteins in renal collecting ducts
C.V1b (V3) receptors in the anterior pituitary gland
D.Alpha-1 adrenergic receptors on peripheral arterioles
Explanation: Arginine vasopressin mediates vasoconstriction primarily via V1a receptors located on vascular smooth muscle cells. V1a receptors are coupled to Gq proteins, activating phospholipase C to generate inositol trisphosphate (IP3) and diacylglycerol (DAG), which releases calcium from the sarcoplasmic reticulum to trigger contraction. Notably, vasopressin maintains vasoconstrictor efficacy even during severe metabolic acidosis, unlike catecholamines.
10Which of the following beta-blockers exhibits non-selective beta-1 and beta-2 antagonism combined with alpha-1 adrenergic receptor blockade, providing balanced afterload reduction in heart failure?
A.Metoprolol succinate
B.Bisoprolol
C.Carvedilol
D.Atenolol
Explanation: Carvedilol is a non-selective beta-adrenergic blocker (blocking beta-1 and beta-2 receptors) that also possesses competitive alpha-1 adrenergic receptor antagonist activity. The alpha-1 blockade produces peripheral arterial vasodilation, decreasing systemic vascular resistance (afterload) and reducing ventricular wall stress, which makes it particularly advantageous in heart failure with reduced ejection fraction.

About the Iraqi Board Cardiology Exam

The Fellowship of the Iraqi Board for Medical Specializations in Cardiology (F.I.B.M.S.) is the premier subspecialty medical qualification in cardiovascular disease awarded in Iraq by the Iraqi Board for Medical Specializations (IBMS), operating under the Ministry of Higher Education and Scientific Research (MOHESR). The 3-year subspecialty fellowship curriculum (following 2 years of internal medicine core residency) equips physicians with comprehensive expertise in cardiac intensive care, coronary artery disease, complex arrhythmias, heart failure, structural and adult congenital heart disease, diagnostic catheterization, and multimodality cardiovascular imaging (echocardiography, cardiac CT, and cardiac MRI). Important disclosure: The complete FIBMS credential requires structured clinical fellowship training, procedural logbook attestation, an approved scientific dissertation, echocardiogram and angiogram interpretation, and structured clinical OSCE/oral viva stations, which cannot be simulated by multiple-choice questions. This 100-question multiple-choice practice bank is an independent English-language educational study resource designed to reinforce theoretical knowledge and clinical decision-making for the Part 1 (Primary) and Part 2 (Final Written) exams. It is not an official IBMS examination, does not provide clinical simulation, and is not a substitute for formal accredited fellowship training.

Exam sponsor: Scientific Council of Cardiology, Iraqi Board for Medical Specializations (المجلس العراقي للاختصاصات الطبية — المجلس العلمي لطب القلب). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Iraqi Board in Cardiology is a structured 3-year subspecialty fellowship (total 5 years postgraduate training following 2 years of core internal medicine residency) administered by the Scientific Council of Cardiology under the Iraqi Board for Medical Specializations (IBMS) and MOHESR. The evaluation framework comprises: 1) Part 1 (Primary) Written Examination, conducted during the fellowship, focusing on foundational cardiovascular physiology, cellular electrophysiology, vascular hemodynamics, cardiovascular pharmacology, and non-invasive diagnostic physics. 2) Periodic in-training assessments, including annual clinical evaluations, case logs, and research dissertation milestones. 3) Part 2 (Final) Examination, sat upon completing all 3 years of accredited clinical rotations and obtaining logbook and dissertation sign-off. The Final Examination comprises written multiple-choice papers (testing coronary artery disease, heart failure, arrhythmias, valvular and congenital heart disease), followed by clinical OSCE stations, echocardiography and coronary angiogram interpretation stations, and an oral viva voce examination.

Time Limit

Not published by the Scientific Council of Cardiology.

Passing Score

Not published. The Scientific Council of Cardiology's published training curriculum sets out training content and rotations but contains no examination regulations, so no pass mark is stated by the council.

Exam / Certification Fees

Prescribed by Iraqi Board for Medical Specializations / MOHESR regulatory bylaws

Exam sponsor website

Reported exam pass rate: Not published. The Scientific Council of Cardiology's published training curriculum sets out training content and rotations but contains no examination section, so pass marks, paper structure, item counts, durations and attempt limits are all unpublished. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

20%

Cardiovascular Physiology, Hemodynamics & Cardiovascular Pharmacology

Cardiac cellular electrophysiology, myocardial mechanics, Frank-Starling law, pressure-volume loops, systemic and pulmonary vascular resistance, autonomic cardiovascular regulation, coronary microcirculation, inotropes, vasopressors, vasodilators, beta-blockers, antiarrhythmic agents, and lipid-lowering pharmacotherapies.

25%

Coronary Artery Disease & Acute Coronary Syndromes

Pathophysiology of atherogenesis and plaque disruption, clinical evaluation of chest pain, STEMI and NSTEMI management algorithms, invasive coronary angiography indications, primary percutaneous coronary intervention (PCI), antiplatelet and antithrombotic regimens, mechanical complications of myocardial infarction, and cardiogenic shock.

20%

Heart Failure, Cardiomyopathies & Pericardial Diseases

Pathogenesis and staging of acute and chronic heart failure (HFrEF, HFmrEF, HFpEF), guideline-directed medical therapy (GDMT: ARNI/ACEi/ARB, beta-blockers, MRA, SGLT2 inhibitors), hypertrophic, dilated, restrictive, and amyloid cardiomyopathies, acute myocarditis, acute pericarditis, constrictive pericarditis, and cardiac tamponade.

18%

Cardiac Electrophysiology, Arrhythmias & Device Therapy

Mechanisms of arrhythmogenesis (reentry, triggered activity, abnormal automaticity), supraventricular tachycardias (AVNRT, AVRT, atrial flutter, atrial fibrillation), stroke prevention and anticoagulation protocols, ventricular tachyarrhythmias, sudden cardiac death risk stratification, permanent pacemakers, cardiac resynchronization therapy (CRT), and implantable cardioverter-defibrillators (ICD).

17%

Valvular Heart Disease, Adult Congenital Heart Disease & Non-invasive Imaging

Etiology, hemodynamics, natural history, and intervention criteria for aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, and tricuspid valve disease; infective endocarditis Duke criteria and antibiotic regimens; atrial septal defect, ventricular septal defect, patent ductus arteriosus, coarctation of aorta, and Tetralogy of Fallot; transthoracic and transesophageal echocardiography, cardiac CT, and cardiac MRI.

Preparing for the Iraqi Board Cardiology Exam

What You Need to Know

  • Passing score: Not published. The Scientific Council of Cardiology's published training curriculum sets out training content and rotations but contains no examination regulations, so no pass mark is stated by the council.
  • Assessment: The Iraqi Board in Cardiology is a structured 3-year subspecialty fellowship (total 5 years postgraduate training following 2 years of core internal medicine residency) administered by the Scientific Council of Cardiology under the Iraqi Board for Medical Specializations (IBMS) and MOHESR. The evaluation framework comprises: 1) Part 1 (Primary) Written Examination, conducted during the fellowship, focusing on foundational cardiovascular physiology, cellular electrophysiology, vascular hemodynamics, cardiovascular pharmacology, and non-invasive diagnostic physics. 2) Periodic in-training assessments, including annual clinical evaluations, case logs, and research dissertation milestones. 3) Part 2 (Final) Examination, sat upon completing all 3 years of accredited clinical rotations and obtaining logbook and dissertation sign-off. The Final Examination comprises written multiple-choice papers (testing coronary artery disease, heart failure, arrhythmias, valvular and congenital heart disease), followed by clinical OSCE stations, echocardiography and coronary angiogram interpretation stations, and an oral viva voce examination.
  • Time limit: Not published by the Scientific Council of Cardiology.
  • Exam / certification fees: Prescribed by Iraqi Board for Medical Specializations / MOHESR regulatory bylaws Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Iraqi Board Cardiology: Suggested Study Strategy

1Master hemodynamics and pressure-volume loops: ensure thorough comprehension of Wiggers diagrams, intracardiac pressure tracings, valve gradients, and calculations of cardiac output (Fick vs thermodilution) and vascular resistances.
2Understand guideline-directed medical therapy (GDMT) inside out: know initiation criteria, titration protocols, monitoring of renal function/potassium, and target dosages for the four foundational drug classes in heart failure (ARNI, beta-blocker, MRA, SGLT2i).
3Study acute coronary syndromes with timing and pharmacology precision: master indications for immediate versus early invasive strategies, antiplatelet choices (ticagrelor/prasugrel vs clopidogrel), anticoagulation regimens, and diagnosis of post-MI mechanical complications.
4Memorize device indications and electrophysiology criteria: clarify exact guideline class I/IIa indications for primary and secondary prevention ICDs, cardiac resynchronization therapy (CRT-P/CRT-D), and pacing modes in sinus node disease and AV block.
5Integrate multimodality imaging with structural and congenital heart disease: practice correlating echocardiographic Doppler findings, cardiac MRI late gadolinium enhancement patterns, and coronary CT calcium scores with surgical or transcatheter intervention thresholds.

Frequently Asked Questions

What is the governing authority and credential awarded by the Iraqi Board in Cardiology?

The program is administered by the Scientific Council of Cardiology under the Iraqi Board for Medical Specializations (IBMS / المجلس العراقي للاختصاصات الطبية), operating under the Ministry of Higher Education and Scientific Research (MOHESR). Successful graduates are awarded the Fellowship of the Iraqi Board for Medical Specializations (F.I.B.M.S.) in Cardiology.

What is the training pathway and examination structure for Iraqi Board cardiology fellows?

The cardiology training program is a 3-year subspecialty fellowship undertaken after completing 2 years of core internal medicine residency (total 5 years postgraduate training). The assessment structure includes: 1) Part 1 (Primary) Written Examination covering cardiovascular physiology, basic hemodynamics, pharmacology, and imaging fundamentals. 2) Continuous in-training evaluation and procedural logbook reviews. 3) Part 2 (Final) Examination comprising written MCQ papers in clinical cardiology, followed by clinical OSCE stations, echocardiography/angiography case interpretation, an oral viva voce examination, and dissertation defense.

What are the pass criteria and retake policies for the written examinations?

The Scientific Council of Cardiology's published training curriculum does not contain an examination section, so no pass mark, paper structure, item count, duration or attempt limit is published for the Part 1 or Part 2 examinations. Candidates should obtain the current assessment regulations directly from the Scientific Council of Cardiology.

What language is used for the Iraqi Board cardiology examinations?

The Iraqi Board for Medical Specializations publishes this council's curriculum, syllabus and reference list in English, and English-language proficiency appears among the admission requirements set by the Ministry. The council's published curriculum does not, however, contain any statement of the language in which the examination papers themselves are set, so no language of assessment is asserted here. This site is an independent English-language study resource and is not affiliated with, endorsed by, or connected to the Iraqi Board for Medical Specializations; candidates should confirm the language of their sitting directly with their Scientific Council.

Does this 100-question practice test simulate clinical echocardiography or replace fellowship training?

No. The Iraqi Board cardiology qualification requires 3 years of rigorous full-time clinical fellowship, hands-on cardiac catheterization, echocardiography and CCU management, logbook attestation, dissertation defense, and structured clinical OSCE/oral examinations. This independent 100-question practice bank is strictly an educational tool to reinforce theoretical and clinical knowledge for the Part 1 and Part 2 written MCQ papers; it is not a clinical simulator or a substitute for formal accredited fellowship training.